You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Current Options and Future Directions in Immune Therapy for Glioblastoma
|
---|---|
Published in |
Frontiers in oncology, December 2018
|
DOI | 10.3389/fonc.2018.00578 |
Pubmed ID | |
Authors |
John Lynes, Victoria Sanchez, Gifty Dominah, Anthony Nwankwo, Edjah Nduom |
X Demographics
The data shown below were collected from the profiles of 42 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 15 | 36% |
Australia | 2 | 5% |
Portugal | 1 | 2% |
Switzerland | 1 | 2% |
United Kingdom | 1 | 2% |
Brazil | 1 | 2% |
China | 1 | 2% |
Italy | 1 | 2% |
Colombia | 1 | 2% |
Other | 0 | 0% |
Unknown | 18 | 43% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 35 | 83% |
Scientists | 5 | 12% |
Science communicators (journalists, bloggers, editors) | 1 | 2% |
Practitioners (doctors, other healthcare professionals) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 85 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 12 | 14% |
Researcher | 11 | 13% |
Student > Master | 9 | 11% |
Student > Ph. D. Student | 7 | 8% |
Student > Doctoral Student | 7 | 8% |
Other | 11 | 13% |
Unknown | 28 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 15 | 18% |
Biochemistry, Genetics and Molecular Biology | 12 | 14% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 6% |
Agricultural and Biological Sciences | 4 | 5% |
Neuroscience | 4 | 5% |
Other | 15 | 18% |
Unknown | 30 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2021.
All research outputs
#1,438,607
of 26,146,017 outputs
Outputs from Frontiers in oncology
#249
of 22,908 outputs
Outputs of similar age
#31,692
of 449,961 outputs
Outputs of similar age from Frontiers in oncology
#4
of 223 outputs
Altmetric has tracked 26,146,017 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,908 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,961 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 223 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.